Real-time Estimate
Cboe Europe
10:50:38 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
0.983
EUR
|
+2.08%
|
|
-6.74%
|
-9.65%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
367.1
|
349.6
|
362.5
|
321.2
|
199.1
|
180.7
|
-
|
-
|
Enterprise Value (EV)
1 |
486.7
|
476.6
|
463.3
|
297.5
|
178.5
|
136
|
139.9
|
245.7
|
P/E ratio
|
50.6
x
|
31.7
x
|
33.4
x
|
-174
x
|
-9.89
x
|
13.8
x
|
10.8
x
|
7.94
x
|
Yield
|
4.44%
|
1.58%
|
2%
|
3.45%
|
6.43%
|
8.31%
|
9%
|
10.4%
|
Capitalization / Revenue
|
0.21
x
|
0.19
x
|
0.19
x
|
0.21
x
|
0.13
x
|
0.12
x
|
0.11
x
|
0.11
x
|
EV / Revenue
|
0.28
x
|
0.26
x
|
0.25
x
|
0.2
x
|
0.12
x
|
0.09
x
|
0.09
x
|
0.15
x
|
EV / EBITDA
|
7.4
x
|
7.61
x
|
6.51
x
|
6.48
x
|
3.43
x
|
4.04
x
|
3.79
x
|
6.19
x
|
EV / FCF
|
7.77
x
|
18.7
x
|
26.9
x
|
3.68
x
|
29.7
x
|
2.62
x
|
10.5
x
|
21.8
x
|
FCF Yield
|
12.9%
|
5.35%
|
3.71%
|
27.2%
|
3.36%
|
38.2%
|
9.54%
|
4.58%
|
Price to Book
|
2.33
x
|
2.02
x
|
1.67
x
|
1.4
x
|
1.16
x
|
1.09
x
|
1.05
x
|
1.02
x
|
Nbr of stocks (in thousands)
|
181,401
|
181,313
|
181,348
|
181,377
|
181,399
|
181,411
|
-
|
-
|
Reference price
2 |
2.025
|
1.902
|
2.005
|
1.740
|
1.088
|
0.9630
|
0.9630
|
0.9630
|
Announcement Date
|
2/7/20
|
2/18/21
|
2/18/22
|
2/16/23
|
2/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,721
|
1,801
|
1,882
|
1,516
|
1,494
|
1,550
|
1,592
|
1,675
|
EBITDA
1 |
65.8
|
62.6
|
71.2
|
45.9
|
52.1
|
33.67
|
36.88
|
39.7
|
EBIT
1 |
20.5
|
21
|
26.3
|
17.8
|
16.7
|
20.57
|
23.71
|
26.25
|
Operating Margin
|
1.19%
|
1.17%
|
1.4%
|
1.17%
|
1.12%
|
1.33%
|
1.49%
|
1.57%
|
Earnings before Tax (EBT)
1 |
10.1
|
14.3
|
14.7
|
6.9
|
-17.6
|
15.18
|
20.33
|
26.54
|
Net income
1 |
8
|
11.3
|
11.3
|
-2.4
|
-20.7
|
11.84
|
16.23
|
22.2
|
Net margin
|
0.46%
|
0.63%
|
0.6%
|
-0.16%
|
-1.39%
|
0.76%
|
1.02%
|
1.33%
|
EPS
2 |
0.0400
|
0.0600
|
0.0600
|
-0.0100
|
-0.1100
|
0.0700
|
0.0888
|
0.1213
|
Free Cash Flow
1 |
62.6
|
25.5
|
17.2
|
80.9
|
6
|
52
|
13.35
|
11.25
|
FCF margin
|
3.64%
|
1.42%
|
0.91%
|
5.34%
|
0.4%
|
3.36%
|
0.84%
|
0.67%
|
FCF Conversion (EBITDA)
|
95.14%
|
40.73%
|
24.16%
|
176.25%
|
11.52%
|
154.44%
|
36.2%
|
28.34%
|
FCF Conversion (Net income)
|
782.5%
|
225.66%
|
152.21%
|
-
|
-
|
439.19%
|
82.24%
|
50.68%
|
Dividend per Share
2 |
0.0900
|
0.0300
|
0.0400
|
0.0600
|
0.0700
|
0.0800
|
0.0867
|
0.1000
|
Announcement Date
|
2/7/20
|
2/18/21
|
2/18/22
|
2/16/23
|
2/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
499
|
372.7
|
394.6
|
480.9
|
374.2
|
354.7
|
383.6
|
352.6
|
386.6
|
375.1
|
401
|
371
|
400
|
EBITDA
1 |
23
|
21.7
|
10.8
|
10.5
|
4.7
|
7.1
|
7
|
8.1
|
8.4
|
7
|
7.9
|
8.4
|
9.75
|
EBIT
1 |
11.6
|
15
|
5.5
|
6.6
|
0.9
|
3.5
|
3.4
|
4.4
|
5.4
|
4
|
4.7
|
5.35
|
6.85
|
Operating Margin
|
2.32%
|
4.02%
|
1.39%
|
1.37%
|
0.24%
|
0.99%
|
0.89%
|
1.25%
|
1.4%
|
1.07%
|
1.17%
|
1.44%
|
1.71%
|
Earnings before Tax (EBT)
1 |
6.8
|
2.7
|
7.3
|
6.7
|
-9.8
|
1.5
|
1.5
|
-19.7
|
-0.9
|
-2
|
-0.5
|
1.5
|
3.65
|
Net income
1 |
5.3
|
8.8
|
12
|
14.6
|
-37.9
|
1.1
|
1.2
|
-20.2
|
-2.8
|
-2.3
|
-1
|
0.8
|
3
|
Net margin
|
1.06%
|
2.36%
|
3.04%
|
3.04%
|
-10.13%
|
0.31%
|
0.31%
|
-5.73%
|
-0.72%
|
-0.61%
|
-0.25%
|
0.22%
|
0.75%
|
EPS
2 |
0.0300
|
0.0500
|
0.0700
|
0.0800
|
-0.2100
|
0.0100
|
0.0100
|
-0.1100
|
-0.0200
|
-0.0100
|
-0.0100
|
-
|
0.0200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/18/22
|
4/28/22
|
7/22/22
|
10/27/22
|
2/16/23
|
4/27/23
|
7/21/23
|
10/31/23
|
2/16/24
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
120
|
127
|
101
|
-
|
-
|
-
|
-
|
65
|
Net Cash position
1 |
-
|
-
|
-
|
23.7
|
20.6
|
44.7
|
40.8
|
-
|
Leverage (Debt/EBITDA)
|
1.818
x
|
2.029
x
|
1.416
x
|
-
|
-
|
-
|
-
|
1.637
x
|
Free Cash Flow
1 |
62.6
|
25.5
|
17.2
|
80.9
|
6
|
52
|
13.4
|
11.3
|
ROE (net income / shareholders' equity)
|
7.82%
|
6.9%
|
5.9%
|
-1.1%
|
-10.4%
|
6.93%
|
9.86%
|
14.3%
|
ROA (Net income/ Total Assets)
|
1.34%
|
1.08%
|
1%
|
-0.23%
|
-2.18%
|
0.28%
|
1.85%
|
2.47%
|
Assets
1 |
596.9
|
1,043
|
1,129
|
1,027
|
947.8
|
4,290
|
877
|
897.2
|
Book Value Per Share
2 |
0.8700
|
0.9400
|
1.200
|
1.240
|
0.9400
|
0.8800
|
0.9200
|
0.9500
|
Cash Flow per Share
2 |
0.4700
|
0.3200
|
0.2200
|
0.4300
|
0.0500
|
0.1600
|
0.1900
|
-
|
Capex
1 |
21.8
|
32.8
|
22.8
|
8.5
|
3.6
|
18.1
|
21.2
|
27.3
|
Capex / Sales
|
1.27%
|
1.82%
|
1.21%
|
0.56%
|
0.24%
|
1.17%
|
1.33%
|
1.63%
|
Announcement Date
|
2/7/20
|
2/18/21
|
2/18/22
|
2/16/23
|
2/16/24
|
-
|
-
|
-
|
Last Close Price
0.963
EUR Average target price
1.125
EUR Spread / Average Target +16.82% Consensus |
1st Jan change
|
Capi.
|
---|
| -9.65% | 193M | | +16.52% | 71.39B | | +1.66% | 25.1B | | -1.22% | 8.59B | | +6.69% | 8.19B | | -20.96% | 7.91B | | +17.12% | 4.31B | | -3.38% | 3.93B | | -2.96% | 3.86B | | +22.08% | 3.64B |
Pharmaceuticals Wholesale
|